Venture Global on Behalf of the Partnership for Safe Medicines
Public health advocacy for safe prescription medicines.
Based in OH
AI Overview
With $195K in lobbying spend across 21 quarterly filings, Venture Global on Behalf of the Partnership for Safe Medicines is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $35K |
| 2022 | $40K |
| 2023 | $40K |
| 2024 | $40K |
| 2025 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Venture Global on Behalf of the Partnership for Safe Medicines disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
Issues related to counterfeit medicines and products, drug pricing, Prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.